Featured Studies

NIH has a study offering the Moderna COVID-19 vaccine for cancer patients who are either currently receiving immune- based treatment for cancer OR patients who have a blood cancer who are receiving treatment now from their doctor, and who have not yet received the COVID-19 vaccine or been infected with the virus that causes COVID19. (En español)

Los NIH tienen un estudio que ofrece la vacuna Moderna para el COVID-19 para pacientes que están recibiendo tratamiento de base inmune para el cáncer o pacientes que tienen un cáncer en la sangre y están recibiendo tratamiento de su doctor, y aún no han recibido la vacuna para el COVID-19 o que no han sido infectados por el virus que causa el COVID- 19.

Do you have Parkinson's disease? Doctors at the National Institute of Neurological Disorders and Stroke (NINDS) are conducting a research study on people with Movement Disorders. They are currently recruiting participants with Parkinson's disease. The purpose is to learn more about the disease and identify genetic changes and other indicators of the condition that may allow earlier diagnosis.There is no cost for study-related tests or procedures. Travel assistance may be provided.

In life neuropsychological functions like memory, attention-processing speed, reading and motors skills play an important role when doing daily activities and should be included when determining treatment options. Currently there are no standardized sets of tests to predict changes in neuropsychological functioning in patients treated with radiation for brain metastases. Doctors at the National Institutes of Health (NIH) are conducting a research study evaluating neuropsychological functions in patients treated for brain metastases.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is conducting a pilot intervention study for patients diagnosed with idiopathic membranous nephropathy. The purpose of this study is to evaluate the safety and effectiveness of Rituximab plus Cyclosporine in the treatment of membranous nephropathy. There is no cost for study-related medications or tests received.

The National Institute of Neurological Disorders and Stroke at the National Institutes of Health Clinical Center is looking for individuals with severe epilepsy or individuals who have experienced persistent seizure activity that cannot be controlled with medication, to participate in this research study. The goal of this research study is to provide surgical treatment to control these types of seizures. Participation requires an inpatient stay of up to 4 weeks, plus 3 outpatient visits within 2 years after surgery.

Researchers at the National Institutes of Health (NIH) are conducting a study to understand fatigue in people with cancer. Fatigue is a common side effect of cancer and its treatment - 96% of cancer patients report experiencing it. Although, there is no compensation for participation, travel assistance to and from study visits may be available.

Researchers at the National Institutes of Health (NIH) Clinical Center are testing if spironolactone can be used to treat PAH. Spironolactone is a medication that can help with fluid retention, however it may also be beneficial to adults with PAH by controlling inflammation and improving blood vessel function in the lungs.

Researchers at the National Institutes of Health seek individuals with kneecap pain (also referred to as patellofemoral or anterior knee pain). We are studying how muscle weakness around the knee may lead to changes in kneecap motion and pain. Understanding what causes kneecap pain may help us to develop better treatments in the future. (En español)

Un grupo de investigadores de los Institutos Nacionales de la Salud (NIH) busca a personas con dolor de rótula (también llamado dolor patelofemoral o de la parte anterior de la rodilla). Estudiamos cómo la debilidad muscular alrededor de la rodilla puede llevar a cambios en la movilidad y el dolor de la rótula. La comprensión de las causas del dolor de rótula nos puede ayudar a diseñar mejores tratamientos en el futuro.